KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Vir Biotechnology (VIR) Other Gross PP&E Adjustments (2018 - 2025)

Vir Biotechnology's Other Gross PP&E Adjustments history spans 8 years, with the latest figure at $25.9 million for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 56.87% to $25.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $25.9 million, a 56.87% increase, with the full-year FY2025 number at $25.9 million, up 56.87% from a year prior.
  • Other Gross PP&E Adjustments hit $25.9 million in Q4 2025 for Vir Biotechnology, down from $35.9 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for VIR hit a ceiling of $56.8 million in Q1 2024 and a floor of -$45.0 million in Q4 2021.
  • Historically, Other Gross PP&E Adjustments has averaged $18.0 million across 5 years, with a median of $27.4 million in 2022.
  • Biggest five-year swings in Other Gross PP&E Adjustments: plummeted 1024.69% in 2021 and later soared 457.58% in 2023.
  • Tracing VIR's Other Gross PP&E Adjustments over 5 years: stood at -$45.0 million in 2021, then soared by 143.47% to $19.5 million in 2022, then grew by 22.06% to $23.9 million in 2023, then tumbled by 30.79% to $16.5 million in 2024, then skyrocketed by 56.87% to $25.9 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for VIR at $25.9 million in Q4 2025, $35.9 million in Q3 2025, and $34.5 million in Q2 2025.